Company profile: Renalogic
1.1 - Company Overview
Company description
- Provider of dialysis cost containment and chronic kidney disease management solutions for self-funded employers, offering care management to prevent CKD progression (ImpactCare), health claims advisory to manage dialysis costs (ImpactProtect), data analysis to identify CKD risks (ImpactIQ), and member advocacy for late-stage CKD and ESRD (ImpactAdvocate).
Products and services
- ImpactCare: Delivers a programmatic, care management service that prevents CKD progression by orchestrating preventive counseling, education, supportive intervention, and care coordination for at‑risk members
- ImpactIQ: Supplies an analytics-driven, data analysis service that identifies CKD risk and incidence, plus related conditions, across the health plan population for targeted interventions
- ImpactProtect: Offers a claims‑administration‑grade, health claims advisory service that manages dialysis costs through claims administration and related processes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Renalogic
Health Data Insights
HQ: United States
Website
- Description: Provider of technology-enabled healthcare services delivering fraud, abuse, and improper payment and overpayment identification and recoupment solutions for government payors, health plans, and employers, specializing in identifying and recouping claim overpayments to providers, including hospitals, physicians, DMEs, and others.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Data Insights company profile →
Free Market Health
HQ: United States
Website
- Description: Provider of a care-driven healthcare technology marketplace and cloud-based platform that empowers payers and pharmacies to reduce specialty drug costs. Offerings include Mercer SelectRx, a solution for employers that lowers specialty drug costs by driving competition among specialty pharmacies, and a platform that manages specialty drug claims to reduce costs for payers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Free Market Health company profile →
Aldera
HQ: United States
Website
- Description: Provider of cloud-based and on-premise core administration solutions for healthcare payers and administrators via a flexible, rules-based platform to meet industry challenges and improve business performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldera company profile →
Guidant Rx
HQ: United States
Website
- Description: Provider of full-service PBM services, offering co-pay card programs, reimbursements, and specialty pharmacy workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guidant Rx company profile →
Wellthy
HQ: United States
Website
- Description: Provider of a family care concierge service that brings relief to families managing complex or ongoing care situations, including aging-related concerns, childcare, special needs, and health conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wellthy company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Renalogic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Renalogic
2.2 - Growth funds investing in similar companies to Renalogic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Renalogic
4.2 - Public trading comparable groups for Renalogic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →